These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18087207)

  • 61. [Does psychoeducational family intervention improve outcome of schizophrenia?].
    Bentsen H
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2571-4. PubMed ID: 14714045
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Family management programmes for schizophrenic patients. Prevention of relapse and modification of familial communication patterns.
    Hahlweg K; Feinstein E; Müller U; Dose M
    Br J Psychiatry Suppl; 1989 Jul; (5):112-6. PubMed ID: 2574982
    [No Abstract]   [Full Text] [Related]  

  • 63. Predictors of outcome in first-episode schizophrenia over the first 4 years of illness.
    Whitty P; Clarke M; McTigue O; Browne S; Kamali M; Kinsella A; Larkin C; O'Callaghan E
    Psychol Med; 2008 Aug; 38(8):1141-6. PubMed ID: 18447960
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Limitations of current therapies: why do patients switch therapies?
    Falkai P
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S135-9. PubMed ID: 18502616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G; Azi A; Noisette C; Yon V
    Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cognitive-behavioural treatment of pathological gambling in individuals with chronic schizophrenia: a pilot study.
    Echeburúa E; Gómez M; Freixa M
    Behav Res Ther; 2011 Nov; 49(11):808-14. PubMed ID: 21920501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of longitudinal changes in schizophrenia: the role of processing speed.
    Sánchez P; Ojeda N; Peña J; Elizagárate E; Yoller AB; Gutiérrez M; Ezcurra J
    J Clin Psychiatry; 2009 Jun; 70(6):888-96. PubMed ID: 19422757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Randomised controlled trial of a behavioural family intervention: 1 year and 11-years follow-up].
    Veltro F; Magliano L; Morosini P; Fasulo E; Pedicini G; Cascavilla I; Falloon I;
    Epidemiol Psichiatr Soc; 2006; 15(1):44-51. PubMed ID: 16584102
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Psychoeducational family treatment in schizophrenia--a popular concept? A critical evaluation of different treatment models].
    Klimitz H
    Psychiatr Prax; 1997 May; 24(3):110-6. PubMed ID: 9273551
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Adherence to therapy in multiple sclerosis and schizophrenia].
    Bussfeld P; Czekalla J
    Fortschr Neurol Psychiatr; 2010 Mar; 78(3):139-46. PubMed ID: 20213580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany].
    Vogel M; Köhnlein O; Schmauss M; Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S173-4. PubMed ID: 15570544
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evaluation of the efficacy of psychoeducative groups in schizophrenic patients].
    Eguiluz I; González Torres MA; Muñoz P; Guadilla M; González G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):29-34. PubMed ID: 9580354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Performance improvement and compliance of schizophrenic patients participating in the computerbased cognitive training with X-Cog].
    Hasmann A; Trapp W; Schwerdtner J; Günther W; Zulley J; Dobmeier M
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S93-5. PubMed ID: 15570516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Schizophrenic patients in the family practice].
    Riedel M; Spellmann I; Müller N; Möller HJ
    MMW Fortschr Med; 2007 May; 149 Suppl 2():98-101. PubMed ID: 17724979
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden.
    Mueser KT; Sengupta A; Schooler NR; Bellack AS; Xie H; Glick ID; Keith SJ
    J Consult Clin Psychol; 2001 Feb; 69(1):3-12. PubMed ID: 11302274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Systemic family therapy in a case of schizophrenic psychosis].
    Merl H
    Psychother Psychosom Med Psychol; 1989 May; 39(5):173-7. PubMed ID: 2734433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A psychosocial skills training approach in Mexican out-patients with schizophrenia.
    Valencia M; Rascon ML; Juarez F; Murow E
    Psychol Med; 2007 Oct; 37(10):1393-402. PubMed ID: 17472761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Unjustly neglected: siblings of people with a schizophrenic psychosis].
    Schrank B; Sibitz I; Schaffer M; Amering M
    Neuropsychiatr; 2007; 21(3):216-25. PubMed ID: 17915182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.